The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

USANA Health Sciences Inc

NYSE: USNA
Last

(U.S.) $139.26

Today's change+0.25 +0.18%
Updated August 24 3:50 PM EDT. Delayed by at least 15 minutes.
 

USANA Health Sciences Inc

NYSE: USNA
Last

(U.S.) $139.26

Today's change+0.25 +0.18%
Updated August 24 3:50 PM EDT. Delayed by at least 15 minutes.

USANA Health Sciences Inc Hits New 20-day High

USANA Health Sciences Inc closed up Wednesday by (U.S.)$0.25 or 0.18% to (U.S.)$139.26 and setting a new 20-day high. Over the last five days, shares have gained 6.31% and 9.01% year to date. Shares have underperformed the S&P 500 by 16.14% during the last year.

Key company metrics

  • Open(U.S.) $139.67
  • Previous close(U.S.) $139.01
  • High(U.S.) $141.41
  • Low(U.S.) $139.04
  • Bid / Ask(U.S.) $139.24 / (U.S.) $139.31
  • YTD % change+9.01%
  • Volume209,004
  • Average volume (10-day)95,889
  • Average volume (1-month)113,561
  • Average volume (3-month)105,403
  • 52-week range(U.S.) $92.00 to (U.S.) $151.18
  • Beta1.16
  • Trailing P/E18.34×
  • P/E 1 year forward17.09×
  • Forward PEG1.71×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $7.59
Updated August 24 3:50 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+10.12%

Based on its net profit margin of 10.12%, USANA Health Sciences Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.95%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Personal Products

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJul 02, 201607/02/2016Apr 02, 201604/02/2016Jan 02, 201601/02/2016Oct 03, 201510/03/2015
Revenue259240233233
Total other revenue--------
Total revenue259240233233
Gross profit213198192192
Total cost of revenue46434041
Total operating expense221207197195
Selling / general / administrative175164157154
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income37343538
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax38333638
Income after tax26222426
Income tax, total12111213
Net income26222426
Total adjustments to net income--------
Net income before extra. items26222426
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items26222426
Inc. avail. to common incl. extra. items26222426
Diluted net income26222426
Dilution adjustment--------
Diluted weighted average shares12131313
Diluted EPS excluding extraordinary itemsvalue per share2.071.771.831.92
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share2.071.771.831.92